跳至主要内容
临床试验/NCT01281618
NCT01281618已完成不适用

Influence of Acid Reflux on Stromal Epithelial Interaction in Barrett's Esophagus

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2008年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
48
试验地点
1
主要终点
activated myofibroblasts

研究概览

简要总结

The purpose of this study is to determine the association between acid reflux and cell changes in Barrett's esophagus.

Specific aim 1: To test the hypothesis that controlled acid reflux is associated with lesser degree of stromal activation.

Specific aim 2: To test the hypothesis that stromal fibroblast derived growth factors drive BE epithelial proliferation.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Prior histological demonstration of Barrett's esophagus that is endoscopically visible; length of visible segment >/= 1 cm
  • Absence of dysplasia or LGD on biopsies within the past 5 years
  • Ability to provide informed consent
  • Age between 18 years and 90 years at study entry.
  • Exclusion criteria:
  • Eastern Cooperative Oncology Group performance status 3 or 4
  • Inability to tolerate endoscopic procedures
  • Pregnancy: Females of child-bearing age will be screened with pregnancy test.
  • Prior esophageal surgery, or cancer

排除标准

  • 未提供

结局指标

主要结局

activated myofibroblasts

时间窗: 6 months

The primary end point for the study will be the proportion of patients with activated myofibroblasts (defined as positive staining for SMA and vimentin with negative staining for Desmin, in \> 50% of subepithelial myofibroblasts). This primary end point will be compared between the group with controlled acid reflux and the group without acid reflux.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Prasad G. Iyer

MD

Mayo Clinic

研究点 (1)

Loading locations...

相似试验